nasal
- Product NDC
- 11822-0304
- 11-digit product format
- 118220304
- Labeler code
- 11822
- Product ID
- 11822-0304_d77b603f-398b-4053-a6d9-9c4caa5b00c9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- oxymetazoline hydrochloride
- Dosage form
- SPRAY
- Route
- NASAL
- Labeler
- Rite Aid Corporation
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2013-12-19
- Substance
- OXYMETAZOLINE HYDROCHLORIDE
- Active strength
- .05 g/100mL
- Pharmacologic classes
- Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- nasal
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXYMETAZOLINE HYDROCHLORIDE | .05 g/100mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | K89MJ0S5VY |
| Rxcui | 1000990 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11822-0304-1 | nasal | 30 mL in 1 BOTTLE | SPRAY | 30 | | 5 |
| 11822-0304-1 | nasal | 1 in 1 CARTON | SPRAY | 1 | | 5 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11822-0304 | NASAL (OXYMETAZOLINE HYDROCHLORIDE) SPRAY [RITE AID CORPORATION] | 5 | Current NDC, Legacy NDC, 2 package rows | 20240811_90e0426b-654f-4bcd-8b1d-cf56d1fc0c68.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11822-0304-1 | 11822030401 | 1 BOTTLE in 1 CARTON (11822-0304-1) / 30 mL in 1 BOTTLE | 1 bottle | 2013-12-19 | 0000-00-00 | No | No | Current |